MCW recently inducted four new researchers into the Society of Research Excellence, which recognizes high-performing scientists. The group aims to foster a collaborative culture that will drive scientific breakthroughs and clinical innovation. Learn more: mcw.edu/mcwknowledge/mcw-sto…

Congratulations to the @Brewers, 2026 World Series champions! Throughout the season, members of the MCW community joined fans across our city at American Family Field to cheer on the team. This historic run brought Milwaukee together in a way few things can, and we are proud to celebrate alongside our neighbors. Thank you, Brewers, for a season our city will never forget. #WinOurWay #WonOurWay

MCW students are helping break merchandise sales in support of the @Brewers! “We gotta go now, or it’s going to be all sold out," said first-year MCW Student Shannon Ruiz. wisn.com/article/brewers-fan…

MCW’s donor-funded BRAVE Program makes a real, tangible difference in the lives of first responders and veterans who have experienced brain injuries. To Bob, the BRAVE program means more than treatment. It means belonging. In just three weeks, participants receive comprehensive treatment, reclaiming their health and rebuilding their lives. Help keep this program free for participants by making a gift at giving.mcw.edu/11-to-11

We were pleased to welcome State Senator @MaryFelzkowski as the first guest of the 2026-27 Public Policy Speaker Series. During her visit, Sen. Felzkowski shared insights on public health policy and emphasized the importance of MCW's work to improve health in Wisconsin.

As a vascular surgeon, MCW’s Kellie Brown, MD ‘93, had a problem: no device existed to safely remove infected stents from aortas. So, in partnership with businessman Brian Thorson, she created one. Learn more: mcw.edu/mcwknowledge/mcw-sto…

Research at the Medical College of Wisconsin is helping pave the way for new approaches to fighting cancer. MCW researcher Jeffrey Medin, PhD, is part of the team behind Tundra Targeted Therapeutics, a Milwaukee-based startup developing a targeted antibody therapy designed to help the immune system recognize and attack cancer cells. The approach aims to offer a new option for cancers that no longer respond to existing treatments, potentially with fewer side effects. The therapy builds on years of academic research conducted at MCW in collaboration with researchers at the University of Virginia. Now, it’s advancing to Phase 1 clinical trials in Milwaukee, bringing research closer to its potential impact on patients.

Big things are happening in Milwaukee, and MCW is cheering on the @Brewers as they take baseball's biggest stage. Have you caught a game at the ballpark or watched from home? Share your favorite photo in the comments! Let's go, Crew! #ThisIsMyCrew #WinOurWay

For more than 50 years, MCW’s Department of Ophthalmology & Visual Sciences has been training ophthalmology residents, and we're now interviewing our next class! Residents train across Froedtert Hospital, Children's Wisconsin, and the Milwaukee VA Hospital, with 2 residents on consults at all times, dedicated wet lab time in each subspecialty rotation, and resident clinics twice a week. With 4 residents per year (16 total), you'll join a close-knit program with a long legacy. Learn more: mcw.edu/departments/ophthalm… #Ophthalmology #Ophthalmologist #Residency #OphthalmologyResident

Congratulations to MCW's Nikki Johnston, PhD, and her startup, N-Zyme Biomedical, on securing $4.6 million in Series A funding! N-Zyme Biomedical is developing therapies that can target pepsin and provide relief for those living with reflux. Learn more: mcw.edu/mcwknowledge/mcw-sto…

MCW first-year medical student Angelo Madruga was inspired by his brothers’ recovery from burn injuries to pursue a career in medicine. Along this journey, Madruga hopes to integrate research and give back to underrepresented communities. Learn more: mcw.edu/mcwknowledge/mcw-sto…

While the heart of their gift is in their hometown, their lasting legacy will extend far beyond. The Mellowes family's $50 million gift to genomic medicine and precision therapeutics will help expand access to exceptional, innovative care in our hometown while ensuring MCW continues to lead the way in making patient-centered, lifelong, personalized care the standard for everyone. We believe precision medicine is the future of healthcare, and we are grateful to the Mellowes for helping accelerate the translation of groundbreaking discoveries into personalized treatments that improve and save lives for generations to come. Read more here: giving.mcw.edu/mellowes

For years, medical treatments have been designed to serve most people. But our genetic makeup offers the key to unlock a deeper understanding of what will work best for each individual patient. This is what inspires Marni J. Falk, MD, the new leader at the helm of the Linda T. and John A. Mellowes Institute for Genomic Medicine and Precision Therapeutics. “I’m honored to join MCW, a pioneer in using genomic sequencing to identify and treat disease, and I’m grateful to the Mellowes family for investing in a future where more people can benefit from this personalized approach to care," Dr. Falk says. A nationally and internationally recognized leader in genomic medicine, mitochondrial disease, and precision therapeutics, Dr. Falk has built and led pioneering clinical and research programs that have advanced the diagnosis and treatment of rare genetic diseases. Read more about Dr. Falk here: giving.mcw.edu/mellowes

Today marks the next chapter in MCW's vision of becoming a destination for health. Delivering world-class precision care and medical education grounded in genomics and data science is a key component of this bold vision and reflects our long history as a pioneer in this evolving field. In 2009, MCW and clinicians from Children's Wisconsin became the first in the world to successfully treat a patient by sequencing their genome. In the years since, MCW’s Center for Genomic Sciences and Precision Medicine has driven translational research that now powers first-in-human clinical trials at Children's Wisconsin and Froedtert Hospital, serving as the nexus for our shared vision of advancing genomic medicine and precision therapeutics. The Mellowes family's latest investment empowers MCW to lead a collaborative effort to make patient-centered, lifelong, personalized care the standard for everyone, starting with universal genome sequencing.

Today, we celebrate a groundbreaking act of generosity that will transform the future of medicine at MCW and beyond. We extend our deepest gratitude to Linda T. and John A. Mellowes and the Charter Manufacturing Foundation for their historic $50 million gift – the largest investment ever made in precision medicine at MCW. In recognition of this landmark gift, MCW’s Center for Genomic Sciences and Precision Medicine will be elevated to the MCW Linda T. and John A. Mellowes Institute for Genomic Medicine and Precision Therapeutics. The Hub for Collaborative Medicine, the vital collaborative space on MCW’s Milwaukee campus, will also be renamed as the Linda T. and John A. Mellowes Health Innovation Center. The Mellowes’ gift reflects progress toward becoming a nationally and internationally recognized collaborative for genomic medicine and precision therapeutics, which aims to tailor treatments to a person’s unique genetic makeup. Through this support, MCW, along with our partners at @childrenswi and @Froedtert, can think bigger and bolder in pursuit of a future where personalized care is the standard for everyone at all stages of life. Read the full story at giving.mcw.edu/mellowes and join us in thanking the Mellowes family for shaping the future of patient care.

Born unable to hear due to a rare genetic condition, sisters Cleo and Lennon have become the first in the U.S. to receive a newly approved gene therapy called Otarmeni. MCW's Dr. Michael Harris is one of two surgeons on their care team. Learn more: jsonline.com/story/news/heal…

MCW researcher Christopher Kristich, PhD, is unraveling the molecular machinery that allows bacteria to evade antibiotics. By doing so, he hopes to devise new ways to overcome antibiotic resistance. Learn more: mcw.edu/mcwknowledge/mcw-sto…

For the Michels family, their daughter Sophie’s childhood cancer diagnosis underlined the need for innovative treatments and expert care. Discover how their journey inspired a transformational investment in cancer care and research to benefit other patients and families. Explore Sophie’s story at giving.mcw.edu/sophies-story

On Oct 9, the Forensic Science and Protective Medicine Facility officially opened during a ribbon-cutting ceremony that brought together leaders from the state, county, and MCW. The building represents a significant investment in public safety & research: biztimes.com/new-245-million…